Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
China Isotope & Radiation Corp. ( (HK:1763) ) has shared an update.
China Isotope & Radiation Corporation has announced its unaudited interim financial results for the first half of 2025, showing comparative figures from the same period in 2024. The publication of these results on both the Stock Exchange and the company’s website highlights CIRC’s commitment to transparency and provides stakeholders with insights into the company’s financial performance and strategic direction.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) is a joint stock company incorporated in the People’s Republic of China. It operates in the isotope and radiation industry, providing products and services related to nuclear technology and radiation applications. The company focuses on leveraging its expertise in this specialized market to serve various sectors.
Average Trading Volume: 512,034
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.65B
For a thorough assessment of 1763 stock, go to TipRanks’ Stock Analysis page.